The results highlight the crucial role of the TGF-β/SMAD4 signaling pathway in regulating vital cellular processes in cancer growth and suggest potential therapeutic options for targeting this pathway in gallbladder cancer [30]. The gene discussed is SMAD4; the disease is cancer.